Skip to content

Calidi Biotherapeutics, Inc.: filings

Every Calidi Biotherapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 20 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 2026441270001493152-26-037847
10-Q2026-05-14fiscal Q1 202642880001493152-26-023140
10-K2026-03-27fiscal FY 202544900001493152-26-013242
10-Q2025-11-13fiscal Q3 2025431300001493152-25-022372
10-Q2025-08-08fiscal Q2 2025431260001641172-25-022797
10-Q2025-05-14fiscal Q1 202544920001641172-25-010317
10-K2025-03-31fiscal FY 202446930001641172-25-001810
10-Q2024-11-12fiscal Q3 2024441340001493152-24-044833
10-Q2024-08-13fiscal Q2 2024431260001493152-24-031688
10-Q2024-05-14fiscal Q1 202442880001493152-24-019305
10-K2024-03-15fiscal FY 202343850001493152-24-010158
10-Q2023-11-14fiscal Q3 2023391180001493152-23-041122
10-Q2023-08-21fiscal Q2 202322670001193125-23-217072
10-Q2023-05-15fiscal Q1 202321460001193125-23-145095
10-K2023-03-31fiscal FY 202226510001193125-23-088349
10-Q2022-11-14fiscal Q3 202223720001193125-22-282874
10-Q2022-08-10fiscal Q2 202220550001193125-22-216531
10-Q2022-05-11fiscal Q1 202218270001193125-22-146662
10-K2022-03-31fiscal FY 202120200001193125-22-090215
10-Q2021-11-12fiscal Q3 202120330001193125-21-328181

Inspect the source

Entity
Calidi Biotherapeutics, Inc. / CIK 0001855485
Captured
2026-09-21T17:32:59.369Z
SEC response SHA-256
cee5bcb17267f2683b0e32bc7855962df8b75eaa8e203dfe43552815b3a9182b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001855485.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))